GETY Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30

cash flows from operating activities:
net income	21,618,000	-34,359,000	-102,572,000	24,723,000	-2,527,000	3,689,000	13,587,000	39,099,000	-18,448,000	-4,277,000	3,203,000	-23,329,000	-103,064,107
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	16,558,000	16,108,000	15,513,000
foreign currency loss on foreign denominated debt
equity-based compensation	4,004,000	3,786,000	4,525,000	4,394,000	4,306,000	4,014,000	9,134,000	10,467,000	9,176,000	11,877,000	6,132,000	3,355,000
debt extinguishment	0	0	5,474,000
deferred income taxes – net	-18,954,000	-28,709,000	54,827,000	3,613,000	-8,244,000	5,303,000	3,422,000	-72,456,000	1,628,000	-5,756,000	-40,000	-4,672,000
uncertain tax positions	-130,000	-1,120,000	502,000	245,000	-712,000	-1,691,000	-163,000	-6,609,000	-2,942,000	-4,232,000	1,222,000	-23,000
non-cash fair value adjustment for swaps
amortization of debt issuance costs	1,503,000	2,395,000	1,923,000	614,000	621,000	540,000	743,000	1,000,000	1,005,000	929,000	1,031,000	1,473,000
non-cash operating lease costs	2,287,000	3,513,000	2,773,000		2,938,000	3,136,000	2,913,000		1,314,000
other	104,000	3,088,000	3,145,000	3,319,000	848,000	862,000	632,000	1,110,000	1,824,000	801,000	723,000	-79,000
changes in assets and liabilities:
accounts receivable	-3,688,000	-237,000	-6,373,000	-19,168,000	-13,631,000	16,442,000	-2,051,000	-10,548,000	-7,862,000	12,427,000	-5,721,000	-3,727,000
accounts payable	1,527,000	-910,000	6,075,000	1,377,000	-696,000	3,437,000	-8,877,000	7,018,000	1,361,000	763,000	657,000	2,395,000	3,608,379
accrued expenses	-37,000	1,577,000	-4,719,000	7,692,000	3,334,000	3,612,000	-212,000	-6,576,000	5,011,000	-164,000	-5,079,000	367,000	-14,972,748
insurance recovery receivable	423,000	2,381,000	5,000,000	969,000	522,000	1,193,000	931,000	11,385,000
litigation reserves	1,504,000	1,507,000	1,501,000	8,823,000	1,323,000	1,309,000	1,390,000	1,438,000
lease liabilities, non-current	-2,796,000	-3,992,000	-3,265,000	-3,451,000	-2,854,000	-3,161,000	-2,957,000	-7,542,000	-1,430,000	-2,193,000	-2,022,000	-396,000
income taxes receivable/payable	148,000	-7,848,000	6,683,000	2,472,000	105,000	-4,110,000	145,000	9,409,000	-219,000	852,000	-2,015,000	4,135,000
interest payable	8,149,000	16,932,000	-7,316,000		-7,328,000	7,315,000	-7,317,000		-6,938,000	7,443,000	-7,573,000	1,271,000
deferred revenue	-6,712,000	-6,325,000	13,167,000	5,649,000	-2,099,000	-10,941,000	7,883,000	2,120,000	-3,204,000	-2,217,000	7,833,000	2,533,000
net cash from operating activities	22,620,000	6,546,000	15,384,000	39,696,000	10,653,000	46,443,000	21,528,000	33,725,000	25,208,000	41,868,000	31,915,000	33,944,000	129,750,084
capex	-14,735,000	-16,111,000	-15,706,000	-15,127,000	-12,490,000	-15,381,000	-14,452,000	-15,131,000	-12,416,000	-13,927,000	-15,525,000	-13,257,000	0
free cash flows	7,885,000	-9,565,000	-322,000	24,569,000	-1,837,000	31,062,000	7,076,000	18,594,000	12,792,000	27,941,000	16,390,000	20,687,000	129,750,084
cash flows from investing activities:
acquisition of property and equipment	-14,735,000	-16,111,000	-15,706,000	-15,127,000	-12,490,000	-15,381,000	-14,452,000	-15,131,000	-12,416,000	-13,927,000	-15,525,000	-13,257,000
acquisition of a business, net of cash acquired				0	-132,000
net cash from investing activities	-14,735,000	-16,111,000	-15,706,000	-15,127,000	-12,622,000	-30,287,000	-14,452,000	-15,131,000	-12,416,000	-13,927,000	-15,525,000	-13,257,000
cash flows from financing activities:
proceeds from issuance of debt	0	0	1,040,872,000
debt refinancing costs	-364,000	-3,853,000	-35,343,000
prepayment and repayments of debt
proceeds from common stock issuance	0			1,684,000	938,000	3,235,000	2,021,000	1,869,000	8,283,000	2,259,000	2,639,000
cash paid for settlement of employee taxes related to equity-based awards					-30,000	-133,000	-2,492,000
net cash from financing activities	-6,769,000	-8,752,000	-12,547,000	-2,352,000	-19,092,000	-29,502,000	-5,272,000	-3,837,000	-16,931,000	-24,535,000	-47,000	-5,714,000	-178,923,000
effects of exchange rates fluctuations	-1,857,000	14,024,000	6,238,000	-11,301,000	9,217,000	842,000	-3,918,000
net increase in cash, cash equivalents and restricted cash				10,916,000	-11,844,000	-12,504,000	-2,114,000	23,054,000	-7,786,000	4,304,000	18,884,000
cash, cash equivalents and restricted cash – beginning of period	0	0	125,304,000		0	0	140,850,000		0	0	102,394,000
cash, cash equivalents and restricted cash – end of period	-741,000	-4,293,000	118,673,000		-11,844,000	-12,504,000	138,736,000		-7,786,000	4,304,000	121,278,000
supplemental disclosures:
interest paid
income taxes paid, including foreign taxes withheld
foreign currency gain (losses) on foreign denominated debt		38,811,000	18,330,000
prepayment of debt		-6,202,000	-1,018,076,000	-2,600,000	-20,000,000
net decrease in cash, cash equivalents and restricted cash		-4,293,000	-6,631,000
depreciation				15,059,000	14,879,000	14,689,000	14,360,000	14,025,000	13,786,000	13,540,000	13,023,000	12,276,000
amortization				590,000	590,000	592,000	534,000	2,304,000	7,298,000	7,260,000	7,207,000	7,969,000
foreign currency (losses) gain on foreign denominated debt
non-cash fair value adjustment for common stock warrants
impairment of equity method investment
non-cash fair value adjustment for swaps and foreign currency exchange contracts								2,526,000	2,322,000	640,000	2,085,000
non cash operating lease costs											1,878,000	335,000
impairment of right of use assets												0
loss on extinguishment of debt												0
transaction costs allocated to common stock warrants
non-cash fair value adjustment of contingent consideration
purchase of a minority investment												0
payment of contingent consideration												0
payment of redeemable preferred stock												0
cash contributions from business combination												0
debt issuance costs				-1,436,000	0	-4,000	-2,201,000
cash paid for settlement of employee taxes related to exercise of equity-based awards								-3,106,000	-2,614,000
cash paid for equity issuance costs								0	0	-64,000	-86,000	-2,916,000
proceeds from option and warrant exercises
redemption of warrants for cash
cash, cash equivalents and restricted cash - beginning of period
cash, cash equivalents and restricted cash - end of period
unrealized exchange gains on foreign denominated debt					19,159,000	-3,420,000	-11,708,000	20,029,000				37,647,000
non-cash fair value adjustment for swaps - net					0	0	1,459,000
repayment of debt							-2,600,000	-2,600,000	-22,600,000	-22,600,000	-2,600,000	-2,600,000
other investing activities
cash paid for debt issuance costs								0	0
effects of exchange rate fluctuations								8,297,000	-3,647,000	898,000	2,541,000	11,019,000
changes in current assets and liabilities:
unrealized exchange loss (gains) on foreign denominated debt										-424,000	9,489,000
non-cash fair value adjustment for warrant liabilties — net
restructuring
non-cash fair value adjustment for swaps and foreign currency exchange contracts — net
transaction cost allocated to common stock warrants												37,000

cash paid for settlement of employee taxes related to option exercises												0
proceeds from option and warrant exercise
change in fair value of derivative liabilities
merger expenses paid by sponsor in exchange for working capital loan
unrealized gain on investments held in trust account
changes in operating assets and liabilities:
prepaid expenses
accrued expenses - related party
non-current accounts payable and accrued expenses
proceeds from working capital loan
net change in cash
cash - beginning of the period
cash - end of the period
●

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.